BioSpace News Archive

Business

AdaptHealth Announces Stephen Griggs Will Step Down as CEO at the End of Second Quarter

AdaptHealth Corp. announced today that Stephen Griggs will step down as Chief Executive Officer by mutual agreement with the Board of Directors, effective June 30, 2023.

May 9, 2023
·
3 min read
Drug Development

FDA Removes Partial Clinical Hold on Salarius Pharmaceuticals’ Phase 1/2 Clinical Trial with Seclidemstat in Patients with Ewing Sarcoma

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) announces that the U.S. Food and Drug Administration (FDA) has removed its partial clinical hold on Salarius’ Phase 1/2 Ewing sarcoma clinical trial evaluating seclidemstat, Salarius’ novel oral, reversible, targeted LSD1 inhibitor.

May 9, 2023
·
10 min read
Galmed Announces Initiation of a Clinical Development Program to Evaluate Aramchol meglumine for the Treatment of Primary Sclerosing Cholangitis (PSC)

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases, announced the initiation of a new clinical program to evaluate its lead compound, Aramchol meglumine for the Treatment of Primary Sclerosing Cholangitis.

May 9, 2023
·
8 min read
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant to Develop Oil-Seed Crops with High CO2 Assimilation and Drought Tolerance

The Ag-Seed Division of Evogene Ltd. has announced that it has been granted a prestigious EU Horizon grant of €1.2 million, to support the creation of oil-seed crops that have high carbon-dioxide assimilation and enhanced drought tolerance.

May 9, 2023
·
8 min read
Alkermes Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Alkermes plc announced the acceptance of two abstracts related to nemvaleukin alfa, the company’s novel, investigational, engineered interleukin-2 variant immunotherapy, for presentation at the American Society of Clinical Oncology Annual Meeting, taking place in Chicago June 2-6, 2023.

May 9, 2023
·
6 min read
Genetown

Kernal Biologics to Present at Locust Walk RNA Innovation Conference

Kernal Bio announced that Yusuf Erkul, M.D., Co-founder & CEO, will present the company’s novel mRNA 2.0 platform at the Locust Walk RNA Innovation Conference on Tuesday, May 9, 2023, at 1:00 p.m. ET.

May 9, 2023
·
2 min read
Genetown

Flare Therapeutics Named to Inc. Magazine’s Annual List of Best Workplaces for 2023

Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, has been named to Inc. magazine’s annual Best Workplaces list.

May 9, 2023
·
3 min read
Business

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2023

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2023.

May 9, 2023
·
10 min read
Business

Seres Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

Seres Therapeutics, Inc., a leading microbiome therapeutics company, reported first quarter 2023 financial results and provided business updates.

May 9, 2023
·
17 min read
Business

Xeris Biopharma Reports First Quarter 2023 Financial Results

Xeris Biopharma Holdings, Inc. today announced financial results for the first quarter ended March 31, 2023, and other corporate highlights.

May 9, 2023
·
10 min read